Evidence map›Paper›PMID 42006507›Full record

ArticleEJIFCC2026

An optimized method for setting Internal Quality Control targets (mean and limits) for multi-instrument Internal Quality Control strategies in hematology?

Tony Badrick, Mathieu Bernard, Lionel Tabard, Jean-Marc Giannoli

Abstract read
In one paragraph

Article in EJIFCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tony BadrickRoyal College of Pathologists of Australasia Quality Assurance Programs, 8 Herbert Street, St Leonards, NSW, Sydney, Australia.
Mathieu BernardBioesterel-Biogroup - Technical Platform, Sanary sur Mer, France.
Lionel TabardBiogroup AURA, Lyon, France.
Jean-Marc GiannoliCerballiance Laboratory, CerbaHealthCare, AURA, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Internal Quality Control (IQC) procedures must evolve as laboratory practices change to meet the requirements of higher patient volumes and the greater need for comparability of results across laboratories. This study developed a strategy to detect significant errors in routine hematology analytical processes using a novel approach to setting IQC material targets (mean and limits) across multiple instruments. This has not been described for hematology laboratories before. Content: The approach described used a common IQC sample mean and limits determined from a manufacturer-based peer group using the same IQC material. The limits involved a new parameter, the random error of the peer group analyzers around their own mean (SD Summary: The model effectively controls analytical error in a network of laboratories using the same measurement system. This model aligns with the best theoretical principles for patient risk reduction and harmonizes practices for acceptance and rejection across the network. Outlook: The model presents an approach to IQC that meets the demands of real-world practice.

Indexed as

components of random error in multi-instrument sitesIQC of multiple analyzerspeer group analyzers statistics

Identifiers

PMID42006507
PMCPMC13088489

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.